Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina, USA.
School of Public Health, University of Nevada, Reno, Nevada, USA.
Environ Health Perspect. 2024 Jul;132(7):77001. doi: 10.1289/EHP14647. Epub 2024 Jul 5.
Organophosphate esters (OPEs), used ubiquitously as flame retardants and plasticizers in consumer products, are suspected of having developmental toxicity.
Our study aimed to estimate associations between prenatal exposure to OPEs and fetal growth, including both ultrasound (head circumference, abdominal circumference, femur length, and estimated fetal weight) and delivery [birth weight -score, small-for-gestational age (SGA), and large-for-gestational age (LGA)] measures of growth.
In the LIFECODES Fetal Growth Study (2008-2018), an enriched case-cohort of 900 babies born at the small and large ends of the growth spectrum, we quantified OPE biomarkers in three urine samples per pregnant participant and abstracted ultrasound and delivery measures of fetal growth from medical records. We estimated associations between pregnancy-averaged log-transformed OPE biomarkers and repeated ultrasound measures of fetal growth using linear mixed-effects models, and delivery measures of fetal growth using linear (birth weight) and logistic (SGA and LGA) regression models.
Most OPE biomarkers were positively associated with at least one ultrasound measure of fetal growth, but associations with delivery measures were largely null. For example, an interquartile range (IQR; ) increase in bis(2-chloroethyl) phosphate concentration was associated with larger -scores in head circumference [mean difference (difference): 0.09; 95% confidence interval (CI): 0.01, 0.17], abdominal circumference (difference: 0.10; 95% CI: 0.02, 0.18), femur length (difference: 0.11; 95% CI: 0.03, 0.19), and estimated fetal weight (difference: 0.13; 95% CI: 0.04, 0.22) but not birth weight (difference: 0.04; 95% CI: , 0.17). At delivery, an IQR () increase in diphenyl phosphate (DPHP) concentration was associated with an SGA birth (odds ratio: 1.46; 95% CI: 1.10, 1.94).
In a large prospective cohort, gestational OPE exposures were associated with larger fetal size during pregnancy, but associations at delivery were null. DPHP concentrations were associated with heightened risk of an SGA birth. These findings suggest that OPE exposure may affect fetal development. https://doi.org/10.1289/EHP14647.
有机磷酸酯 (OPE) 作为消费品中的阻燃剂和增塑剂被广泛使用,它们被怀疑具有发育毒性。
本研究旨在评估产前暴露于 OPE 与胎儿生长之间的关联,包括超声(头围、腹围、股骨长度和估计胎儿体重)和分娩[出生体重 - 评分、小于胎龄儿 (SGA) 和大于胎龄儿 (LGA)]生长测量。
在 LIFECODES 胎儿生长研究(2008-2018 年)中,我们对出生在生长谱小端和大端的 900 名婴儿进行了丰富的病例 - 队列研究,对每位孕妇的三份尿液样本进行了 OPE 生物标志物定量,并从病历中提取了胎儿生长的超声和分娩测量值。我们使用线性混合效应模型估计妊娠平均对数转换的 OPE 生物标志物与重复超声测量的胎儿生长之间的关联,并使用线性(出生体重)和逻辑(SGA 和 LGA)回归模型估计与分娩测量的胎儿生长之间的关联。
大多数 OPE 生物标志物与至少一项超声测量的胎儿生长呈正相关,但与分娩测量的关联大多为零。例如,二(2-氯乙基)磷酸酯浓度的四分位距(IQR; )增加与头围[平均差异(差异):0.09;95%置信区间(CI):0.01,0.17]、腹围(差异:0.10;95% CI:0.02,0.18)、股骨长度(差异:0.11;95% CI:0.03,0.19)和估计胎儿体重(差异:0.13;95% CI:0.04,0.22)的评分增加有关,但与出生体重(差异:0.04;95% CI: ,0.17)无关。在分娩时,二苯基磷酸酯(DPHP)浓度的 IQR( )增加与 SGA 出生有关(比值比:1.46;95% CI:1.10,1.94)。
在一项大型前瞻性队列研究中,妊娠期 OPE 暴露与妊娠期间胎儿大小增加有关,但分娩时的关联为零。DPHP 浓度与 SGA 出生的风险增加有关。这些发现表明,OPE 暴露可能会影响胎儿发育。https://doi.org/10.1289/EHP14647.